Physician profile
Michael C Durkin
NPI 1962594606
$537,806.02
in general payments reported to CMS, 2019-2025
17 companies · $89K in 2025
The $89K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $36K · 2021: $69K · 2022: $81K · 2023: $94K · 2024: $90K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $193K · Travel and Lodging: $77K · Food and Beverage: $3,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $192,700.00 |
| Travel and Lodging | $76,721.28 |
| Food and Beverage | $3,356.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $535,032.32 | 2019-2025 | Mako, Aequalis, Accolade |
| Moximed, INC | $1,111.37 | 2025 | Misha Knee System, Small, Left |
| Medwest Associates | $635.00 | 2019 | |
| Heron Therapeutics, INC. | $243.93 | 2019-2025 | Zynrelef |
| Depuy Synthes Sales INC. | $234.84 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $178.25 | 2019-2025 | Zilretta, Iovera, Exparel |
| Ferring Pharmaceuticals INC. | $118.11 | 2023-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $48.74 | 2024-2025 | |
| Baudax Bio INC. | $41.36 | 2022 | |
| Medical Device Business Services, INC. | $33.62 | 2022 | |
| Orthofix Medical, INC. | $27.04 | 2024-2025 | Physio-Stim |
| Smith+Nephew, INC. | $24.04 | 2024 | Acticoat 4" X 4", Pico 14 |
| Janssen Pharmaceuticals, INC | $21.69 | 2021 | |
| Orthalign INC | $18.50 | 2023 | Orthalign Plus |
| Pacira Therapeutics, INC. | $13.17 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $12.11 | 2019 | |
| Arthrosurface Incorporated | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Durkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.